Literature DB >> 11964147

Association of thrombospondin-1 with the actin cytoskeleton of human thrombin-activated platelets through an alphaIIbbeta3- or CD36-independent mechanism.

Anne Saumet1, Nando de Jesus, Chantal Legrand, Véronique Dubernard.   

Abstract

Thrombospondin-1 (TSP-1) is an adhesive glycoprotein which, when secreted from alpha-granules of activated platelets, can bind to the cell surface and participate in platelet aggregate formation. In this study, we show that thrombin activation leads to the rapid and specific association of a large amount of secreted alpha-granular TSP-1 with the actin cytoskeleton. This cytoskeletal association of TSP-1 was correlated with platelet secretion, but not aggregation, and was inhibited by cytochalasin D, an inhibitor of actin polymerization. Association of TSP-1 with the actin cytoskeleton was mediated by membrane receptors, as shown by using MAII, a TSP-1-specific monoclonal antibody that inhibited both TSP-1 surface binding to activated platelets and cytoskeletal association. TSP-1 and its potential membrane receptors, e.g. alphaIIbbeta3 integrin, CD36 and CD47, concomitantly associated with the actin cytoskeleton. However, studies on platelets from a patient with type I Glanzmann's thrombasthenia lacking alphaIIbbeta3 and another with barely detectable CD36 showed normal TSP-1 surface expression and association with the actin cytoskeleton. Likewise, no involvement of CD47 in TSP-1 association with the actin cytoskeleton could be inferred from experiments with control platelets using the function-blocking anti-CD47 antibody B6H12. Finally, assembly of signalling complexes, as observed through translocation of tyrosine-phosphorylated proteins and kinases to the actin cytoskeleton, was found to occur in concert with cytoskeletal association of TSP-1, in control platelets as well as in thrombasthenic and CD36-deficient platelets. Our results imply a role for the actin cytoskeleton in the membrane-surface expression process of TSP-1 molecules and suggest a possible coupling of TSP-1 receptors to signalling events occurring independently of alphaIIbbeta3 or CD36. These results provide new insights into the link between surface-bound TSP-1 and the contractile actin microfilament system which may promote platelet aggregate cohesion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11964147      PMCID: PMC1222499          DOI: 10.1042/0264-6021:3630473

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  47 in total

1.  Focal adhesion assembly.

Authors:  K Burridge; M Chrzanowska-Wodnicka; C Zhong
Journal:  Trends Cell Biol       Date:  1997-09       Impact factor: 20.808

2.  Characterization of the binding of thrombospondin to human platelets and its association with the platelet cytoskeleton.

Authors:  V Dubernard; C Legrand
Journal:  J Lab Clin Med       Date:  1991-11

3.  Reversible translocation of phosphoinositide 3-kinase to the cytoskeleton of ADP-aggregated human platelets occurs independently of Rho A and without synthesis of phosphatidylinositol (3,4)-bisphosphate.

Authors:  C Gachet; B Payrastre; C Guinebault; C Trumel; P Ohlmann; G Mauco; J P Cazenave; M Plantavid; H Chap
Journal:  J Biol Chem       Date:  1997-02-21       Impact factor: 5.157

Review 4.  Glanzmann's thrombasthenia: the spectrum of clinical disease.

Authors:  J N George; J P Caen; A T Nurden
Journal:  Blood       Date:  1990-04-01       Impact factor: 22.113

5.  Reassessment of protein tyrosine phosphorylation in thrombasthenic platelets: evidence that phosphorylation of cortactin and a 64-kD protein is dependent on thrombin activation and integrin alphaIIb beta3.

Authors:  J P Rosa; V Artçanuthurry; F Grelac; J Maclouf; J P Caen; S Lévy-Toledano
Journal:  Blood       Date:  1997-06-15       Impact factor: 22.113

Review 6.  The structural and functional properties of thrombospondin.

Authors:  J Lawler
Journal:  Blood       Date:  1986-05       Impact factor: 22.113

7.  Thrombspondin acts via integrin-associated protein to activate the platelet integrin alphaIIbbeta3.

Authors:  J Chung; A G Gao; W A Frazier
Journal:  J Biol Chem       Date:  1997-06-06       Impact factor: 5.157

8.  An integrin receptor on normal and thrombasthenic platelets that binds thrombospondin.

Authors:  J Lawler; R O Hynes
Journal:  Blood       Date:  1989-11-01       Impact factor: 22.113

9.  Expression of intracellular fibrinogen on the surface of stimulated platelets.

Authors:  G Courtois; J J Ryckewaert; V L Woods; M H Ginsberg; E F Plow; G A Marguerie
Journal:  Eur J Biochem       Date:  1986-08-15

10.  Interaction of thrombospondin with platelet glycoproteins GPIa-IIa and GPIIb-IIIa.

Authors:  M A Kowalska; G P Tuszynski
Journal:  Biochem J       Date:  1993-11-01       Impact factor: 3.857

View more
  4 in total

Review 1.  The use of CD47-modified biomaterials to mitigate the immune response.

Authors:  Jillian E Tengood; Robert J Levy; Stanley J Stachelek
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-10

2.  Surface Glycoproteins of Exosomes Shed by Myeloid-Derived Suppressor Cells Contribute to Function.

Authors:  Sitara Chauhan; Steven Danielson; Virginia Clements; Nathan Edwards; Suzanne Ostrand-Rosenberg; Catherine Fenselau
Journal:  J Proteome Res       Date:  2016-10-20       Impact factor: 4.466

3.  Role of Thrombospondin-1 in Mechanotransduction and Development of Thoracic Aortic Aneurysm in Mouse and Humans.

Authors:  Yoshito Yamashiro; Bui Quoc Thang; Seung Jae Shin; Caroline Antunes Lino; Tomoyuki Nakamura; Jungsil Kim; Kaori Sugiyama; Chiho Tokunaga; Hiroaki Sakamoto; Motoo Osaka; Elaine C Davis; Jessica E Wagenseil; Yuji Hiramatsu; Hiromi Yanagisawa
Journal:  Circ Res       Date:  2018-08-31       Impact factor: 17.367

4.  Hantavirus Infection Suppresses Thrombospondin-1 Expression in Cultured Endothelial Cells in a Strain-Specific Manner.

Authors:  Svetlana F Khaiboullina; Sergey P Morzunov; Stephen C St Jeor; Albert A Rizvanov; Vincent C Lombardi
Journal:  Front Microbiol       Date:  2016-07-19       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.